Cite
HARVARD Citation
Maguire, J. et al. (n.d.). 146: Therapeutic advantage of concurrent chemoradiotherapy with 55 Gy/20 fractions with cisplatinum and vinorelbine assessed by comparing control rates predicted by radio-biological (Biosuite) software and clinical results. Lung cancer. pp. S53-. [Online].